Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 156

Sort by

Sort Order Select

Journal Articles

A Machine Learning Algorithm to Improve Risk Assessment for Patients with Sickle Cell Disease

Vandana Sachdev, MD, Yuan Gu, PhD, James Nichols, RN, Wen Li, RCS, Stanislav Sidenko, RCS, Darlene Allen, MT(ASCP), Colin Wu, PhD, Swee Lay Thein, DSc, MBBS

Blood (2019) 134 (Supplement_1): 893.

https://doi.org/10.1182/blood-2019-125846

Published: 2019

Journal Articles

Combination of Phosphodiesterase 4 (PDE4) Inhibitor Roflumilast and R-CHOP As First-Line Therapy for High-Risk Diffuse Large B Cell Lymphoma Patients

Adolfo E Diaz, MD, Matthew James Butler, MD, Anand Karnad, MD, Ricardo Aguiar, MD PhD

Blood (2019) 134 (Supplement_1): 1592.

https://doi.org/10.1182/blood-2019-124382

Published: 2019

Journal Articles

Amyloidosis and Plasma Cell Dyscrasias: A Single Institution Experience

Poornima Ramadas, MBBS, Ajay Tambe, MBBS, Mijung Lee, MD

Blood (2019) 134 (Supplement_1): 5463.

https://doi.org/10.1182/blood-2019-131577

Published: 2019

Journal Articles

Non-Hematologic Therapy Toxicities Correlated with Survival, Drug Discontinuation and Response in Multiple Myeloma Patients: A Retrospective Study

Weimin Huang, PhD, Yongqiang Wei, PhD, Jingxia Zheng, Xiaolei Wei, PhD, Ru Feng, MD

Blood (2019) 134 (Supplement_1): 5496.

https://doi.org/10.1182/blood-2019-126751

Published: 2019

Journal Articles

Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory t[11;14] Multiple Myeloma

Diana Basali, MD, Rajshekhar Chakraborty, MD, Lisa Rybicki, MS, Nathaniel Rosko, PharmD, Janice Reed, RN, Mary Ann Karam, RN, Kristen Schlueter, RN, Hayley Dysert, Beth M. Faiman, PhDCNP, Kimberly Hamilton, APRN/PA, Matt Kalaycio, MD, Jason Valent, MD

Blood (2019) 134 (Supplement_1): 5566.

https://doi.org/10.1182/blood-2019-129002

Published: 2019

Journal Articles

Role of Echocardiography and Cardiac Biomarkers in Early Detection of Hematopoietic Stem Cell Transplantation Associated Cardiotoxicity

Ana Carolina Oliver, MD, Roberto Superchi, MD, Superchi Federico, MD, Canabal Matilde, MD, Jubin Silvana, Lic, Carolina Errecarte, MD, Caneiro Ada, MD, Silvia Pierri, MD, Sebastian Galeano, MD, Eloisa Riva, MD, Bello Laura, MD, Regis Gai, MD, Miller Andrew, MD, Pablo J. Muxi, MD, Ricardo Fabian Mosquera, MD

Blood (2019) 134 (Supplement_1): 5688.

https://doi.org/10.1182/blood-2019-127680

Published: 2019

Journal Articles

Transfusion-Dependent Low Risk Myelodysplastic Syndrome (TD LR-MDS): Predictors Ofcardiovascular Events and Death

Marta Alonso Fernández de Gatta, MD PhD, Ana Martín García, MD PhD, Félix López Cadenas, MD, Díaz Peláez Elena, MD, Tamara Jimenez, Jesus Maria . Hernández-Rivas, MD, Victor Vallejo García, MD, Manuel Barreiro Pérez, MD, Lucia Rodríguez Estévez, MD, Juan Carlos Castro Garay, Diego Ávila, MD, Adolfo Alejandro Cabanillas Cabral, MD, Clara Sánchez Pablo, MD, María Díez-Campelo, MD PhD, Pedro Luís Sánchez Fernández, MD PhD

Blood (2019) 134 (Supplement_1): 1727.

https://doi.org/10.1182/blood-2019-127938

Published: 2019

Journal Articles

AL amyloidosis cardiac staging updated using BNP

Christopher P. Venner

Blood (2019) 133 (3): 184–185.

https://doi.org/10.1182/blood-2018-10-882159

Published: 2019

Journal Articles

BNP-based staging system in AL amyloidosis

Blood (2019) 133 (3): 286.

https://doi.org/10.1182/blood-2018-12-889998

Published: 2019

Journal Articles

Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis

Brian Lilleness, Frederick L. Ruberg, Roberta Mussinelli, Gheorghe Doros, Vaishali Sanchorawala

Blood (2019) 133 (3): 215–223.

https://doi.org/10.1182/blood-2018-06-858951

Published: 2019

Journal Articles

A Novel Mass Spectrometry Method to Identify the Serum Monoclonal Light Chain Component and Infer Organ Involvement in Systemic Light Chain Amyloidosis

Faye Sharpley, Richa Manwani, MBBS, FRCPath, BSc, Shameem Mahmood, Sajitha Sachchithanantham, Helen Lachmann, Julian Gillmore, Carol Whelan, Philip Hawkins, Ashutosh D. Wechalekar

Blood (2018) 132 (Supplement 1): 4445.

https://doi.org/10.1182/blood-2018-99-114028

Published: 2018

Journal Articles

Clinical Characteristics and Outcome of Patients with Wild-Type Transthyretin and AL Cardiac Amyloidosis Confirmed By Mass Spectrometry

Stephen Parkin, MD BSc, Michael A. Seidman, MD FRCPC, Margot Davis, MD FRCPC, Kevin Song, MD

Blood (2018) 132 (Supplement 1): 3126.

https://doi.org/10.1182/blood-2018-99-115317

Published: 2018

Journal Articles

Responses and Cardiotoxicity with R-CDOP and R-CHOP Observed in Frontline Therapy for Patients with Primary Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL): A Randomized Phase-IV Study from Multiple Centers in China

Lili Feng, MD PhD, Xiaoxia Chu, Hongguo Zhao, MD, Yili Wang, Jie Li, Ying Li, MD, Xuehong Ran, Jie Min, Lingyan Zhang, MD, Hongzhi Xu, Jingxia Wang, Ling Wang, Yunliang Hao, Ruirong Xu, Juan Fan, MD, Lei Wang, Xin Wang, MD PhD

Blood (2018) 132 (Supplement 1): 2960.

https://doi.org/10.1182/blood-2018-99-116295

Published: 2018

Journal Articles

Comparison of Different Techniques to Identify Cardiac Involvement in Immunoglobulin Light Chain Amyloidosis

Blood (2018) 132 (Supplement 1): 3182.

https://doi.org/10.1182/blood-2018-99-117627

Published: 2018

Journal Articles

Characterization of Cardiovascular Adverse Events and B-Type Natriuretic Peptide Levels in Patients with Multiple Myeloma Who Are Treated with Carfilzomib

Hang Quach, MDFRACP,FRCPA,MBBS, Khue Minh Nguyen, Matthew Ku, MBBS, FRACP, FRCPA, Ali Bazargan, MBBS FRACP FRCPA, Robin J Filshie, PhDFRACP,FRCPA, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Lisa Catherine Demosthenous, MPH, BSN, David Prior, MBBS FRACP PhD

Blood (2018) 132 (Supplement 1): 1956.

https://doi.org/10.1182/blood-2018-99-113802

Published: 2018

Journal Articles

Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed By Autologous Stem Cell Transplantation for AL Amyloidosis: Long Term Follow-up Analysis

Vishal K Gupta, MD, Dina Brauneis, NP, Anthony C Shelton, RN, Karen Quillen, MD MPH, John Mark Sloan, MD, Vaishali Sanchorawala, MD

Blood (2018) 132 (Supplement 1): 4616.

https://doi.org/10.1182/blood-2018-99-111551

Published: 2018

Journal Articles

N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) Is Associated with Both Left Ventricular Diastolic Dysfunction and Myeloma-Related Renal Insufficiency and Robustly Predicts Mortality in Patients with Symptomatic Multiple Myeloma

Yoshiaki Abe, Tetsuya Kobayashi, MD, Kentaro Narita, MD, Hiroki Kobayashi, MD, Akihiro Kitadate, MD PhD, Masami Takeuchi, MD, Kosei Matsue, MD PhD

Blood (2018) 132 (Supplement 1): 4478.

https://doi.org/10.1182/blood-2018-99-110064

Published: 2018

Journal Articles

Phase II Clinical Study of the Clinical Efficacy and Safety of Tosedostat in Patients with Myelodysplastic Syndromes (MDS) after Failure of Hypomethylating Agent-Based Therapy

Sangmin Lee, MD, Pinkal Desai, MDMPH, Bianca Edirisinghe, Samantha Pianello, Jack W. Singer, MD, Michael Samuel, MD, Ellen K Ritchie, MD, Gail J. Roboz, MD

Blood (2017) 130 (Supplement 1): 2966.

https://doi.org/10.1182/blood.V130.Suppl_1.2966.2966

Published: 2017

Journal Articles

Novel Cardiac Biopsy Scoring Tool to Predict Clinical Outcomes in Cardiac Light Chain (AL) Amyloidosis

Ujjawal H Gandhi, PhDMBBS, Hanna Von Haefen, Robert Hoffman, MD PhD, Alexandra Ritts, MD, Sharon Phillips, MSPH, Oluchi Ukaegbu, MD, Samuel Rubinstein, MD, Shelton Lacy Harrell, MSN, Stacey A. Goodman, MD MS, Daniel Lenihan, MD, David Slosky, MD, Rebecca Hung, MD PhD, Robert Frank Cornell, MD

Blood (2017) 130 (Supplement 1): 1881.

https://doi.org/10.1182/blood.V130.Suppl_1.1881.1881

Published: 2017

Journal Articles

Persisting Cardiac Dysfunction and Quality of Response Predict Survival in Patients with AL Amyloidosis Who Respond to Upfront Therapy

Giovanni Palladini, MDPhD, Paolo Milani, MD, Marco Basset, MD, Francesca Russo, MD, Andrea Foli, MD, Giampaolo Merlini, MD

Blood (2017) 130 (Supplement 1): 4346.

https://doi.org/10.1182/blood.V130.Suppl_1.4346.4346

Published: 2017

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

A Machine Learning Algorithm to Improve Risk Assessment for Patients with Sickle Cell Disease

Combination of Phosphodiesterase 4 (PDE4) Inhibitor Roflumilast and R-CHOP As First-Line Therapy for High-Risk Diffuse Large B Cell Lymphoma Patients

Amyloidosis and Plasma Cell Dyscrasias: A Single Institution Experience

Non-Hematologic Therapy Toxicities Correlated with Survival, Drug Discontinuation and Response in Multiple Myeloma Patients: A Retrospective Study

Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory t[11;14] Multiple Myeloma

Role of Echocardiography and Cardiac Biomarkers in Early Detection of Hematopoietic Stem Cell Transplantation Associated Cardiotoxicity

Transfusion-Dependent Low Risk Myelodysplastic Syndrome (TD LR-MDS): Predictors Ofcardiovascular Events and Death

AL amyloidosis cardiac staging updated using BNP

BNP-based staging system in AL amyloidosis

Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis

A Novel Mass Spectrometry Method to Identify the Serum Monoclonal Light Chain Component and Infer Organ Involvement in Systemic Light Chain Amyloidosis

Clinical Characteristics and Outcome of Patients with Wild-Type Transthyretin and AL Cardiac Amyloidosis Confirmed By Mass Spectrometry

Responses and Cardiotoxicity with R-CDOP and R-CHOP Observed in Frontline Therapy for Patients with Primary Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL): A Randomized Phase-IV Study from Multiple Centers in China

Comparison of Different Techniques to Identify Cardiac Involvement in Immunoglobulin Light Chain Amyloidosis

Characterization of Cardiovascular Adverse Events and B-Type Natriuretic Peptide Levels in Patients with Multiple Myeloma Who Are Treated with Carfilzomib

Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed By Autologous Stem Cell Transplantation for AL Amyloidosis: Long Term Follow-up Analysis

N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) Is Associated with Both Left Ventricular Diastolic Dysfunction and Myeloma-Related Renal Insufficiency and Robustly Predicts Mortality in Patients with Symptomatic Multiple Myeloma

Phase II Clinical Study of the Clinical Efficacy and Safety of Tosedostat in Patients with Myelodysplastic Syndromes (MDS) after Failure of Hypomethylating Agent-Based Therapy

Novel Cardiac Biopsy Scoring Tool to Predict Clinical Outcomes in Cardiac Light Chain (AL) Amyloidosis

Persisting Cardiac Dysfunction and Quality of Response Predict Survival in Patients with AL Amyloidosis Who Respond to Upfront Therapy

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only